8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

February 14, 2018

Date of Report (Date of Earliest Event Reported)

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

Delaware	001-36794	46-4845564
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
Of Incorporation)	File Number)	Identification No.)

1007 Market Street

Wilmington, Delaware, 19899

(Address of principal executive offices)

Registrant’s telephone number, including area code: (302) 773-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.	☐

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b)  On February 14, 2018, The Chemours Company (the “Company”) announced that Stephen D. Newlin, a member of the Company’s Board of Directors (the “Board”), informed the Board that he will not stand for reelection and will retire from the Board at the Company’s 2018 Annual Meeting. A copy of the press release is attached hereto as Exhibit 99.1.

Item 9.01Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press release dated February 14, 2018.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CHEMOURS COMPANY
By:	/s/  Mark E. Newman
	Mark E. Newman
	Senior Vice President and
	Chief Financial Officer
Date:	February 14, 2018

EX-99.1

EXHIBIT 99.1

The Chemours Company Announces Changes to its Board of Directors

Wilmington, Del., February 14, 2018 – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced that board member Stephen D. Newlin will not seek reelection to the Chemours Board of Directors; he will continue to serve on the Board for the remainder of his term until the company’s 2018 Annual Meeting.  

Chemours Chairman of the Board, Richard H. Brown, made clear his appreciation for Mr. Newlin’s contributions: “We thank Steve for his dedicated service to Chemours. He’s played an important role in the company’s success to date. That said, we understand and fully support his pursuit of a more desirable work-life balance, and wish him all the best in his future pursuits.”

Mr. Newlin has been a member of The Chemours Company Board of Directors since the company’s formation as an independent company in July 2015. Said Chemours President and CEO Mark Vergnano, “Steve’s presence has resulted in many significant accomplishments for the company, including the dramatic transformation of Chemours into the strong, fiscally healthy organization it is today.”

Vergnano added, “We are extremely grateful for the work he has done, work that has helped lay the very foundation we will build upon as we move Chemours into its next exciting chapter of growth.”

In making the decision not to seek reelection, Mr. Newlin cited the need for more personal time. “Having been with Chemours since the beginning,” he said, “has been an honor and a pleasure for me. Now is the right time for me to spend more time with my family as the company is in a great place, has completed its transformation plan, and is pivoting to a growth strategy. I am confident in the leadership of the company and in its future.”

About The Chemours Company

The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing.  Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe.  

Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com.

CONTACT

MEDIA

Alvenia Scarborough

Director of Brand Marketing and Corporate Communications

+1.302.773.4507

media@chemours.com

EXHIBIT 99.1

INVESTORS

Alisha Bellezza

Treasurer and Director of Investor Relations

+1.302.773.2263

investor@chemours.com